Erectile Dysfunction–our new study reveals trends, R&D progress, and predicted revenues
Where is the erectile dysfunction market heading? If you are involved in this sector you must read this newly updated report. The report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead
Our 168 pages report provides 88 tables, 85 charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Erectile Dysfunction Market. See how to exploit the opportunities.

Forecasts to 2030 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there are following segments, each forecasted at a global and regional level.

Erectile Dysfunction Market by Type


  • Viagra (Sildenafil Citrate)
  • Cialis (Tadalafil)
  • Levitra/ Staxyn (Vardenafil)
  • Stendra/Spedra (Avanafil)
  • Zydena (Udenafil)
  • Vitaros (alprostadil)


Dietary Supplements:

  • DHEA
  • VIgRX Plus
  • IDIProst
  • Prelox
  • Tradamix TX 1000
  • Others


  • Horny Goat Weed
  • Ginko
  • Red Ginseng
  • Yohimbine
  • Panax Ginseng
  • Cappra
  • Pyongenol
  • Lepidamax
  • Others


Erectile Dysfunction Market by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 4 regional and 15 leading national markets:

North America

  • U.S.
  • Canada


  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe

Asia pacific

  • Japan
  • China
  • India
  • Australia
  • Rest of Asia Pacific

Rest of the World

  • Brazil
  • Mexico
  • GCC
  • South Africa
  • Rest of ROW

The report also includes profiles and for some of the leading companies in the erectile dysfunction market.

Leading companies and the potential for market growth
Overall world revenue for Erectile Dysfunction Market will surpass $2,500 million in 2020, our work calculates. We predict noticeable revenue growth through to 2030.

Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Erectile Dysfunction Market report helps you
In summary, our 169 pages report provides you with the following knowledge:

Revenue forecasts to 2030 for 5 regional and 17 key national markets
See forecasts for the Erectile Dysfunction market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, Australia, ASEAN countries, GCC Countries and South Africa.

Prospects for established firms and those seeking to enter the market
Including company profiles for 10 of the major companies involved in the erectile dysfunction market:

  • Bayer AG
  • Eli Lilly and Company
  • Ferring B.V.
  • GSK
  • Pfizer Inc.
  • Teva Pharmaceuticals
  • Vivus Inc.
  • Dong Pharmaceuticals
  • SK Chemicals Co Ltd.
  • Apricus Biosciences Inc.